Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-01-25 @ 1:51 AM
Study NCT ID:
NCT01923233
Status:
WITHDRAWN
Last Update Posted:
2020-01-22
First Post:
2013-08-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer
Sponsor:
Mirror Biologics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ITL-017-HCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None